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mons pubis and the right pelvic and inguinofemoral lymph nodes. The
symphysis pubis was partly removed and the right pectineus muscle
was resected; the rectus sheath and the rectus muscle were reﬁxated
onto the remainder of the symphysis pubis. The skin of the left lower ab-
domen was transposed to cover the defect. A laparoscopic tubal ligation,
removal of the LNG-IUS and dilatation and curettage (D&C) were also
performed. During laparoscopy no evidence of endometriosis was seen;
the D&C demonstrated a normal endometrial mucosa without atypia.Case report
Wehere present the case of a 44-year-old nullipara (BMI 28.7 kg/m2)
with no signiﬁcant past gynecological, medical or surgical history
other than an open appendectomy. She presented to the general sur-
geons with a subcutaneous lump on the mons pubis that had been
monitored for about one year. MRI showed a polycystic mass of
30 mm × 18 mm × 18 mm size that was excised and described as
an adenocarcinoma on the basis of endometriosis (Fig. 1).
Gynecological examination and transvaginal pelvic ultrasound were
normal. The patient had an intra-uterine device (IUD) in-situ, which
had been placed for contraceptive purposes only. PAP smear and
tumormarkers (CEA, AFP, CA 12-5, CA 19-9, CA 15-3, SCC) were all nor-
mal. Repeat MRI showed partly solid, partly cystic post-operative resid-
uals in the right inguinal region, extending up to the right edge of the
symphysis pubis with uncertain boney inﬁltration. A PET and a CT
scan revealed pathological lymph nodes on the right and one lesion in
the left inguinal region. The patient was transferred to our Department
for tertiary care. Following discussion by the Gynecologic Cancer Inter-
Group (GCIC), the residual tumor was removed one month after the
initial surgery. This involved a multidisciplinary team of gynecologic,Gynecology, InnsbruckMedical
ria. Fax: +43 50504 23055.
c.Open access under CC BY license.The histology report revealed large areas of highly differentiated
endometrioid adenocarcinoma and small areas of adeno-squamous as
well as serous-papillary differentiation. The tumor margins were free.
Furthermore, areas of endometriosis without atypia were seen. All
12 lymph nodes resected were tumor-free. Immunohistochemistry
conﬁrmed the presence of estrogen and progesterone receptors, as
well as expression of the L1 cell adhesion molecule (L1CAM) in the
endometriotic and the tumor tissue.
Following a further discussion by the Gynecologic Cancer Inter-Group
(GCIC) the patient was to receive six cycles of adjuvant chemotherapy
with carboplatin/paclitaxel and local radiotherapy. During the ﬁrst cycle
of chemotherapy the patient developed a major anaphylactic reaction.
She also reacted to the alternative option of pegylated liposomal doxoru-
bicin and docetaxel. Finally a combination of epirubicin and carboplatin
was tolerated well and the remaining cycles could be administered with-
out unexpected toxicities. The patient received local radiotherapy with
5000 cGy in 25 fractions to the area of the previous malignancy as well
as up to 6000 cGy in ﬁve further fractions to the whole operating ﬁeld.
She was followed up clinically and paraclinically for the last three years
and remains well with no evidence of tumor recurrence.Discussion
The current literature includes one case of inguinal endometriosis
(Jubanyik and Comite, 1997). However, to our knowledge this is the
ﬁrst case documenting ectopic endometrium in the mons pubis.
Endometriosis usually affects women of reproductive age and has a
prevalence of 10% (Wheeler, 1989). Its etiology is controversial, with
common opinion being that endometriosis develops via retrogrademen-
struation,whereby theuterine endometrial glands and stromamainly im-
plant onto surfaces and organs of the pelvis (Jubanyik and Comite, 1997).
In the malignant transformation of endometriosis the ovary is the
primary site in 79% of all cases (Hoang et al., 2005). Extragonadal sites,
Fig. 1. Endometroid CA within endometriotic cyst.
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are identiﬁed in 21% (Hoang et al., 2005). Themalignant transformation
of endometriosis is rare and the case presented here is certainly highly
unusual with a novel location of endometriosis and its malignant trans-
formation in a pre-menopausal woman. The histology report revealed
features of Type I and Type II endometrial cancer, with highly differen-
tiated adenocarcinoma having developed next to serous-papillary dif-
ferentiated tissue. Both cancerous and endometriotic tissues were
positive for L1CAM-antibodies, which are associated with a high risk
of tumor relapse and short survival rates (Zeimet et al., 2013).Nevertheless, after a three year follow-up there is no evidence of disease
recurrence.
In this case the possibility of metastasis from a uterine primary was
excluded. Nevertheless, we cannot exclude the possibility of endometri-
osis implantation at the time of an earlier appendectomy. The surgical
incision was therebymade in the right lower quadrant. An oophorecto-
my at the time of surgical resection was not considered in this patient,
however, it could certainly be deliberated in future cases given that
the ovary is the most common site of endometriosis-associated
adenocarcinoma. There are multiple possible explanations for the pre-
malignant potential of endometriosis. Pollacco et al., for example, pro-
pose an endometriosis-induced carcinoma (EIC) triad, with endocrino-
logical and immunological factors aswell as genomic alterations leading
to the malignant transformation of the endometriotic tissue (Pollacco
et al., 2012). Certainly, more research needs to be conducted to analyze
the possible mechanisms of cancer formation from endometriosis.
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